Advertisement
EyeGate Pharmaceuticals I... (EYEG)
NASDAQ: EYEG
· Real-Time Price · USD
35.26
0.08 (0.23%)
At close: Apr 28, 2025, 3:07 PM
0.23% (1D)
| Bid | 35.2 |
| Market Cap | 26.71M |
| Revenue (ttm) | 20K |
| Net Income (ttm) | -5.63M |
| EPS (ttm) | -1.768 |
| PE Ratio (ttm) | -19.94 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 35.38 |
| Volume | 395 |
| Avg. Volume (20D) | 1,393 |
| Open | 35.17 |
| Previous Close | 35.18 |
| Day's Range | 35.17 - 35.26 |
| 52-Week Range | 33.92 - 37.24 |
| Beta | 0.27 |
About EYEG
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. The company is headquartered in Waltham, Massachusetts and currently employs 11 full-time employees. The firm is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The firm's lead product...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 13, 2015
Employees 14
Stock Exchange NASDAQ
Ticker Symbol EYEG
Website http://www.eyegatepharma.com